triple glp-1/gip/glucagon receptor agonist Retatrutide: The powering superior fat loss. GLP-1 + GIP + Glucagon = up to 24% body weight reduction in trials. Clinical results. Real transformation. #Retatrutide #GLP1 #FatLoss" Upcoming wave of hormone-based therapies
Description
Mucosal Immunol (2020) 13:63751
He Z, Tabe AN, Rana S, King K
For the bioinformatic analysis, the quality of the data was evaluated using the standard RNA-seq quality control parameters, and the differentially expressed genes were identified using the R-package DESeq2
showed that liraglutide 3.0 mg/day significantly decreased body weight, BMI, WC and Waist to Hip ratio (W/H) compared with the placebo group [62]
In fact, GLP-1 medications produce some of the largest weight loss results 2 seen with pharmaceutical treatments
In direct comparison trials for diabetes (SURPASS-2 compared tirzepatide to semaglutide 1 mg), tirzepatide showed superior blood sugar control and greater weight loss
